FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030199647> ?p ?o ?g. }

• W2030199647 endingPage "2843" @default.
• W2030199647 startingPage "2836" @default.
• W2030199647 abstract "Mel-18 is a member of the polycomb group (PcG) proteins, which are chromatin regulatory factors and play important roles in development and oncogenesis. This study was designed to investigate the clinical and prognostic significance of Mel-18 in patients with prostate cancer. A total of 539 native Japanese subjects consisting of 393 prostate cancer patients and 146 controls were enrolled in this study. Mel-18 genotyping was analyzed using a PCR-RFLP method and an automated sequencer using the GENESCAN software. Immunohistochemistry revealed that Mel-18 expression was diminished in high grade and high stage prostate cancers. Moreover, patients with positive Mel-18 expression had significantly longer PSA recurrence-free survival than patients negative for Mel-18 expression (p=0.038). A Mel-18 1805A/G SNP was located in the 3' untranslated region and was predicted to alter the secondary structure of the mRNA. Mel-18 mRNA expression of the 1805A allele was clearly higher than expression of the 1805G allele by allele specific quantitative RT-PCR. In multivariate analysis, a homozygous G allele genotype and negative Mel-18 expression were independent risk factors predicting high PSA recurrence after radical prostatectomy, with HRs of 2.757 (p=0.022) and 2.271 (p=0.045), respectively. Moreover, the G allele was also an independent predictor of poor cancer-specific survival with an HR of 4.658 (p=0.019) for patients with stage D2 prostate cancer. This is the first study to provide important evidence demonstrating that Mel-18 is a tumor suppressor and possible therapeutic target, as well as a diagnostic marker for poor prognosis in prostate cancer patients." @default.
• W2030199647 created "2016-06-24" @default.
• W2030199647 creator A5012066043 @default.
• W2030199647 creator A5023820231 @default.
• W2030199647 creator A5027892519 @default.
• W2030199647 creator A5036373532 @default.
• W2030199647 creator A5041711088 @default.
• W2030199647 creator A5046597133 @default.
• W2030199647 creator A5047951647 @default.
• W2030199647 creator A5062022557 @default.
• W2030199647 creator A5073304157 @default.
• W2030199647 creator A5073793600 @default.
• W2030199647 creator A5076550313 @default.
• W2030199647 creator A5083025134 @default.
• W2030199647 creator A5089375452 @default.
• W2030199647 creator A5091592429 @default.
• W2030199647 date "2009-08-24" @default.
• W2030199647 modified "2023-10-15" @default.
• W2030199647 title "The novel tumor-suppressor Mel-18 in prostate cancer: Its functional polymorphism, expression and clinical significance" @default.
• W2030199647 cites W1536466400 @default.
• W2030199647 cites W1967633197 @default.
• W2030199647 cites W1974326568 @default.
• W2030199647 cites W1977836335 @default.
• W2030199647 cites W1985825541 @default.
• W2030199647 cites W1994328631 @default.
• W2030199647 cites W2023984097 @default.
• W2030199647 cites W2050926837 @default.
• W2030199647 cites W2103253228 @default.
• W2030199647 cites W2103392842 @default.
• W2030199647 cites W2114641334 @default.
• W2030199647 cites W2114762637 @default.
• W2030199647 cites W2118436380 @default.
• W2030199647 cites W2125534706 @default.
• W2030199647 cites W2130439102 @default.
• W2030199647 cites W2140664731 @default.
• W2030199647 cites W2151025094 @default.
• W2030199647 cites W2151163394 @default.
• W2030199647 cites W2158827722 @default.
• W2030199647 cites W2166666333 @default.
• W2030199647 cites W2167724857 @default.
• W2030199647 doi "https://doi.org/10.1002/ijc.24721" @default.
• W2030199647 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19585577" @default.
• W2030199647 hasPublicationYear "2009" @default.
• W2030199647 type Work @default.
• W2030199647 sameAs 2030199647 @default.
• W2030199647 citedByCount "28" @default.
• W2030199647 countsByYear W20301996472012 @default.
• W2030199647 countsByYear W20301996472013 @default.
• W2030199647 countsByYear W20301996472014 @default.
• W2030199647 countsByYear W20301996472015 @default.
• W2030199647 countsByYear W20301996472016 @default.
• W2030199647 countsByYear W20301996472017 @default.
• W2030199647 countsByYear W20301996472018 @default.
• W2030199647 countsByYear W20301996472020 @default.
• W2030199647 countsByYear W20301996472021 @default.
• W2030199647 countsByYear W20301996472022 @default.
• W2030199647 crossrefType "journal-article" @default.
• W2030199647 hasAuthorship W2030199647A5012066043 @default.
• W2030199647 hasAuthorship W2030199647A5023820231 @default.
• W2030199647 hasAuthorship W2030199647A5027892519 @default.
• W2030199647 hasAuthorship W2030199647A5036373532 @default.
• W2030199647 hasAuthorship W2030199647A5041711088 @default.
• W2030199647 hasAuthorship W2030199647A5046597133 @default.
• W2030199647 hasAuthorship W2030199647A5047951647 @default.
• W2030199647 hasAuthorship W2030199647A5062022557 @default.
• W2030199647 hasAuthorship W2030199647A5073304157 @default.
• W2030199647 hasAuthorship W2030199647A5073793600 @default.
• W2030199647 hasAuthorship W2030199647A5076550313 @default.
• W2030199647 hasAuthorship W2030199647A5083025134 @default.
• W2030199647 hasAuthorship W2030199647A5089375452 @default.
• W2030199647 hasAuthorship W2030199647A5091592429 @default.
• W2030199647 hasConcept C104317684 @default.
• W2030199647 hasConcept C121608353 @default.
• W2030199647 hasConcept C126322002 @default.
• W2030199647 hasConcept C135763542 @default.
• W2030199647 hasConcept C139275648 @default.
• W2030199647 hasConcept C143998085 @default.
• W2030199647 hasConcept C153209595 @default.
• W2030199647 hasConcept C180754005 @default.
• W2030199647 hasConcept C204232928 @default.
• W2030199647 hasConcept C2776235491 @default.
• W2030199647 hasConcept C2779466945 @default.
• W2030199647 hasConcept C2780192828 @default.
• W2030199647 hasConcept C31467283 @default.
• W2030199647 hasConcept C502942594 @default.
• W2030199647 hasConcept C54355233 @default.
• W2030199647 hasConcept C555283112 @default.
• W2030199647 hasConcept C63363279 @default.
• W2030199647 hasConcept C71924100 @default.
• W2030199647 hasConcept C86803240 @default.
• W2030199647 hasConceptScore W2030199647C104317684 @default.
• W2030199647 hasConceptScore W2030199647C121608353 @default.
• W2030199647 hasConceptScore W2030199647C126322002 @default.
• W2030199647 hasConceptScore W2030199647C135763542 @default.
• W2030199647 hasConceptScore W2030199647C139275648 @default.
• W2030199647 hasConceptScore W2030199647C143998085 @default.
• W2030199647 hasConceptScore W2030199647C153209595 @default.
• W2030199647 hasConceptScore W2030199647C180754005 @default.

• next